Tianjin Lisheng Pharmaceutical Co.,Ltd. (SHE:002393)
China flag China · Delayed Price · Currency is CNY
16.81
-0.10 (-0.59%)
Apr 29, 2026, 3:04 PM CST

SHE:002393 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
5,1805,5624,5114,8103,9173,943
Market Cap Growth
21.17%23.28%-6.20%22.78%-0.65%5.98%
Enterprise Value
2,7753,5912,3662,7362,4912,354
Last Close Price
16.8117.3513.8014.2411.4711.48
PE Ratio
12.5113.3624.4513.2941.8532.29
Forward PE
-18.1818.1818.1818.1818.18
PS Ratio
3.824.003.384.173.423.61
PB Ratio
1.121.190.940.980.900.89
P/TBV Ratio
1.181.261.001.010.930.92
P/FCF Ratio
24.1226.48130.7234.7813.4936.48
P/OCF Ratio
20.7622.4751.1124.0511.8220.08
EV/Sales Ratio
2.052.581.772.372.172.16
EV/EBITDA Ratio
14.9721.5016.0214.7919.7326.77
EV/EBIT Ratio
25.4838.4234.0823.0740.8082.13
EV/FCF Ratio
12.9217.1068.5419.798.5721.78
Debt / Equity Ratio
0.010.010.010.010.010.01
Debt / EBITDA Ratio
0.240.270.340.180.350.39
Debt / FCF Ratio
0.210.221.480.240.160.32
Net Debt / Equity Ratio
-0.53-0.54-0.48-0.45-0.45-0.37
Net Debt / EBITDA Ratio
-13.45-15.04-15.70-11.82-15.43-18.39
Net Debt / FCF Ratio
-11.36-11.96-67.17-15.81-6.71-14.96
Asset Turnover
0.240.250.230.210.220.21
Inventory Turnover
2.852.943.122.602.392.03
Quick Ratio
4.174.063.754.053.283.75
Current Ratio
4.524.374.104.503.604.26
Return on Equity (ROE)
8.86%8.94%3.83%7.82%2.14%2.80%
Return on Assets (ROA)
1.20%1.03%0.75%1.34%0.73%0.35%
Return on Invested Capital (ROIC)
4.66%3.75%2.30%3.99%1.86%0.92%
Return on Capital Employed (ROCE)
2.30%1.90%1.40%2.30%1.30%0.60%
Earnings Yield
7.97%7.49%4.09%7.52%2.39%3.10%
FCF Yield
4.15%3.78%0.77%2.88%7.41%2.74%
Dividend Yield
5.91%4.32%2.11%2.51%1.56%1.56%
Payout Ratio
41.91%23.30%65.59%15.13%58.48%14.94%
Buyback Yield / Dilution
0.70%-0.26%0.83%-0.59%-0.70%-5.91%
Total Shareholder Return
6.61%4.06%2.95%1.92%0.86%-4.35%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.